Furthermore, mesenchymal stem cell (MSC)-derived EVs are linked to liver inflammation and NASH progress, and are associated with increased proinflammatory markers (TNF-α, IL-1β, IL-6, and IL-12) [73]. Here, IL1B is linked to metabolic dysfunction-associated steatohepatitis.